Skip to main content
main-content

05-06-2020 | ASCO 2020 | Conference coverage | Video

Researcher comment: Ribociclib efficacy for visceral metastases

Denise Yardley reports on the outcomes of participants with visceral metastases in the MONALEESA-3 and MONALEESA-7 trials of ribociclib for hormone receptor-positive, HER2-negative breast cancer (8:54).

Read transcript

Have your say on Medicine Matters

Visit the conference hub

Image Credits